RSP

RSP remains in a Stage 2 advancing regime, trading above its rising EMAs within a clear uptrend but showing overbought conditions and minor exhaustion signals. Under the Stable strategy, execution should be deferred, stalking for a pullback into the 9/21 EMA support zone to confirm absorption of recent weakness before committing.

• ↑+0.61% gain to $213.50, near 52-week high of $216.37.
• ↑MACD turned bullish June 29; similar signals saw 86% upside success.
• ↓5-day change down 0.57%, highlighting recent price volatility.